Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand 
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
REDWOOD CITY, Calif., Sept. 28, 2016 -- Dextera Surgical Inc. (Nasdaq:DXTR) today announced the company’s schedule of key lecture presentations at the 30th European Association for Cardio-Thoracic Surgery (EACTS) annual meeting, the largest gathering of cardiothoracic surgeons in the world, to be held Oct. 1 – 5 at the Centre Convencions Internacional de Barcelona in Barcelona, Spain.
Innovative approaches to cardiothoracic procedures using the company’s MicroCutter 5/80 surgical stapling technology will be presented by Joel Dunning, M.D., cardiothoracic surgeon at James Cook University Hospital, Department of Cardiothoracic Surgery in Middlesbrough, U.K. and Ruoyu Zhang, M.D., thoracic surgeon at Klinik Schillerhoehe, Department of Thoracic Surgery in Gerlingen, Germany.
Key presentations are as follows (all times Central European Time):
Saturday 10/1/16
1:30 p.m., Room 113 – Beyond Conventional Video Assisted Thoracic Surgery: Part 2
- Advanced stapling techniques/microcutters with J. Dunning
Monday 10/3/16
2:30 p.m., Room 129/130 – VATS Lobectomy
- Microlobectomy, a novel form of VATS lobectomy with J. Dunning
3:15 p.m., Room 129/130 – VATS Lobectomy
- Clinical outcomes of thorascopic lobectomy in patients with moderate and severe comorbidity with R. Zhang, T. Kyriss and G. Friedel
About Dextera Surgical
Dextera Surgical designs and manufactures proprietary stapling devices for minimally invasive surgical procedures. In the U.S., surgical staplers are routinely used in more than one million minimally invasive laparoscopic, video-assisted or robotic-assisted surgical procedures annually.
The company's signature proprietary technology, the MicroCutter 5/80 Stapler, is the world's first and only five-millimeter surgical stapler that articulates to 80 degrees in each direction. As the smallest-profile articulating stapler available today, the MicroCutter 5/80 Stapler may reduce the amount of dissection and tissue handling required to position the stapler in confined spaces, enabling access to difficult-to-reach anatomy. The cartridge-based device's small size and wide articulation range are designed to enhance the surgeon's access and visualization at the surgical site and to mitigate limitations on the advancement of minimally invasive surgical approaches created by larger stapling devices.
Dextera Surgical also markets the only automated anastomosis devices for coronary artery bypass graft (CABG) surgery on the market today: the C-Port® Distal Anastomosis Systems and PAS-Port® Proximal Anastomosis System. These products, sold by Dextera Surgical under the Cardica brand name, have demonstrated long-term reliable clinical performance for more than a decade.
MicroCutter Indication Information
The MicroCutter 5/80 Stapler is manufactured and cleared for use in the United States for transection and resection in multiple open or minimally invasive urologic, thoracic and pediatric surgical procedures, as well as application for transection, resection and/or creation of anastomoses in the small and large intestine, and the transection of the appendix. The MicroCutter 30 White Reload has application in vascular tissue.
Contact: Investors: Bob Newell Vice President, Finance and Chief Financial Officer (650) 331-7133 [email protected] Media: Jessica Volchok (310) 849-7985 [email protected]
